Friday, 5 July 2024
  
Login

Australia's most trusted
source of pharma news

Friday, 05 July 2024
Listen to this story 
News

Antidepressant in product recall

Posted 30 November 2023 PM

The TGA is investigating nitrosamine impurities in two genericised antidepressant meds with Alphapharm's product already recalled.

Duloxetine and fluoxetine belong to the drug class known as selective serotonin reuptake inhibitors (SSRIs) and are both used to treat major depression. Duloxetine is also indicated for pain and anxiety disorders while fluoxetine is also used for obsessive-compulsive disorder, and premenstrual dysphoric disorder.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (24)

Clinical & Medical, R&D (12)

Regulatory, Pharmacovigilance & QA (8)

Other (21)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.